nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Atrioventricular block complete—Chenodeoxycholic acid—primary biliary cirrhosis	0.0337	0.036	CcSEcCtD
Remifentanil—Atrioventricular block complete—Ursodeoxycholic acid—primary biliary cirrhosis	0.0337	0.036	CcSEcCtD
Remifentanil—Pericarditis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0272	0.0291	CcSEcCtD
Remifentanil—Pericarditis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0272	0.0291	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.0249	0.0266	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.0191	0.0203	CcSEcCtD
Remifentanil—Heartburn—Chenodeoxycholic acid—primary biliary cirrhosis	0.0171	0.0183	CcSEcCtD
Remifentanil—Heartburn—Ursodeoxycholic acid—primary biliary cirrhosis	0.0171	0.0183	CcSEcCtD
Remifentanil—Pleural effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.0154	0.0164	CcSEcCtD
Remifentanil—Pleural effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.0154	0.0164	CcSEcCtD
Remifentanil—Oliguria—Colchicine—primary biliary cirrhosis	0.0142	0.0152	CcSEcCtD
Remifentanil—Urinary incontinence—Ursodeoxycholic acid—primary biliary cirrhosis	0.0114	0.0121	CcSEcCtD
Remifentanil—Urinary incontinence—Chenodeoxycholic acid—primary biliary cirrhosis	0.0114	0.0121	CcSEcCtD
Remifentanil—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.0109	0.0116	CcSEcCtD
Remifentanil—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0105	CcSEcCtD
Remifentanil—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0105	CcSEcCtD
Remifentanil—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00979	0.0104	CcSEcCtD
Remifentanil—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00979	0.0104	CcSEcCtD
Remifentanil—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00911	0.00972	CcSEcCtD
Remifentanil—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00911	0.00972	CcSEcCtD
Remifentanil—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00903	0.00963	CcSEcCtD
Remifentanil—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00903	0.00963	CcSEcCtD
Remifentanil—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00899	0.00959	CcSEcCtD
Remifentanil—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00899	0.00959	CcSEcCtD
Remifentanil—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00789	0.00842	CcSEcCtD
Remifentanil—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00739	0.00789	CcSEcCtD
Remifentanil—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00739	0.00789	CcSEcCtD
Remifentanil—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00711	0.00759	CcSEcCtD
Remifentanil—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00711	0.00759	CcSEcCtD
Remifentanil—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00709	0.00756	CcSEcCtD
Remifentanil—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00709	0.00756	CcSEcCtD
Remifentanil—Haematuria—Colchicine—primary biliary cirrhosis	0.007	0.00747	CcSEcCtD
Remifentanil—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00691	0.00738	CcSEcCtD
Remifentanil—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00691	0.00738	CcSEcCtD
Remifentanil—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00663	0.00708	CcSEcCtD
Remifentanil—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00663	0.00708	CcSEcCtD
Remifentanil—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00648	0.00692	CcSEcCtD
Remifentanil—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00648	0.00692	CcSEcCtD
Remifentanil—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00632	0.00674	CcSEcCtD
Remifentanil—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00632	0.00674	CcSEcCtD
Remifentanil—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00629	0.00671	CcSEcCtD
Remifentanil—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00629	0.00671	CcSEcCtD
Remifentanil—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00595	0.00635	CcSEcCtD
Remifentanil—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00595	0.00635	CcSEcCtD
Remifentanil—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00594	0.00634	CcSEcCtD
Remifentanil—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00592	0.00632	CcSEcCtD
Remifentanil—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00592	0.00632	CcSEcCtD
Remifentanil—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00587	0.00627	CcSEcCtD
Remifentanil—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00587	0.00627	CcSEcCtD
Remifentanil—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.0057	0.00609	CcSEcCtD
Remifentanil—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.0057	0.00609	CcSEcCtD
Remifentanil—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00549	0.00586	CcSEcCtD
Remifentanil—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00549	0.00586	CcSEcCtD
Remifentanil—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00537	0.00573	CcSEcCtD
Remifentanil—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00537	0.00573	CcSEcCtD
Remifentanil—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00535	0.0057	CcSEcCtD
Remifentanil—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00535	0.0057	CcSEcCtD
Remifentanil—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00533	0.00569	CcSEcCtD
Remifentanil—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00533	0.00569	CcSEcCtD
Remifentanil—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00531	0.00567	CcSEcCtD
Remifentanil—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00531	0.00567	CcSEcCtD
Remifentanil—Anaemia—Colchicine—primary biliary cirrhosis	0.0053	0.00566	CcSEcCtD
Remifentanil—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00529	0.00564	CcSEcCtD
Remifentanil—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00529	0.00564	CcSEcCtD
Remifentanil—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00476	0.00508	CcSEcCtD
Remifentanil—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00476	0.00508	CcSEcCtD
Remifentanil—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00462	0.00493	CcSEcCtD
Remifentanil—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00462	0.00493	CcSEcCtD
Remifentanil—Shock—Colchicine—primary biliary cirrhosis	0.0046	0.00491	CcSEcCtD
Remifentanil—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00459	0.0049	CcSEcCtD
Remifentanil—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00458	0.00489	CcSEcCtD
Remifentanil—Skin disorder—Colchicine—primary biliary cirrhosis	0.00455	0.00485	CcSEcCtD
Remifentanil—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00453	0.00483	CcSEcCtD
Remifentanil—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00453	0.00483	CcSEcCtD
Remifentanil—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.0045	0.0048	CcSEcCtD
Remifentanil—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.0045	0.0048	CcSEcCtD
Remifentanil—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00446	0.00476	CcSEcCtD
Remifentanil—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00446	0.00476	CcSEcCtD
Remifentanil—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00445	0.00475	CcSEcCtD
Remifentanil—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00445	0.00475	CcSEcCtD
Remifentanil—Hypotension—Colchicine—primary biliary cirrhosis	0.00437	0.00467	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00436	0.00465	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00436	0.00465	CcSEcCtD
Remifentanil—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00429	0.00458	CcSEcCtD
Remifentanil—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00429	0.00458	CcSEcCtD
Remifentanil—Alfentanil—ALB—primary biliary cirrhosis	0.00426	0.689	CrCbGaD
Remifentanil—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00424	0.00452	CcSEcCtD
Remifentanil—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00424	0.00452	CcSEcCtD
Remifentanil—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00449	CcSEcCtD
Remifentanil—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.0042	0.00449	CcSEcCtD
Remifentanil—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00414	0.00441	CcSEcCtD
Remifentanil—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00414	0.00441	CcSEcCtD
Remifentanil—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00412	0.0044	CcSEcCtD
Remifentanil—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00412	0.0044	CcSEcCtD
Remifentanil—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00412	0.00439	CcSEcCtD
Remifentanil—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00412	0.00439	CcSEcCtD
Remifentanil—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0041	0.00438	CcSEcCtD
Remifentanil—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0041	0.00438	CcSEcCtD
Remifentanil—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00436	CcSEcCtD
Remifentanil—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00436	CcSEcCtD
Remifentanil—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00434	CcSEcCtD
Remifentanil—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00434	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00404	0.00431	CcSEcCtD
Remifentanil—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00419	CcSEcCtD
Remifentanil—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00419	CcSEcCtD
Remifentanil—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00403	CcSEcCtD
Remifentanil—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00378	0.00403	CcSEcCtD
Remifentanil—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00375	0.004	CcSEcCtD
Remifentanil—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00375	0.004	CcSEcCtD
Remifentanil—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00374	0.00399	CcSEcCtD
Remifentanil—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00374	0.00399	CcSEcCtD
Remifentanil—Urticaria—Colchicine—primary biliary cirrhosis	0.00372	0.00397	CcSEcCtD
Remifentanil—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0037	0.00395	CcSEcCtD
Remifentanil—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0037	0.00395	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00363	0.00387	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00363	0.00387	CcSEcCtD
Remifentanil—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00384	CcSEcCtD
Remifentanil—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00384	CcSEcCtD
Remifentanil—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00384	CcSEcCtD
Remifentanil—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00384	CcSEcCtD
Remifentanil—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.0037	CcSEcCtD
Remifentanil—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.0037	CcSEcCtD
Remifentanil—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00345	0.00368	CcSEcCtD
Remifentanil—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00334	0.00356	CcSEcCtD
Remifentanil—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00334	0.00356	CcSEcCtD
Remifentanil—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00332	0.00355	CcSEcCtD
Remifentanil—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00332	0.00355	CcSEcCtD
Remifentanil—Diarrhoea—Colchicine—primary biliary cirrhosis	0.0032	0.00342	CcSEcCtD
Remifentanil—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00331	CcSEcCtD
Remifentanil—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00331	CcSEcCtD
Remifentanil—Vomiting—Colchicine—primary biliary cirrhosis	0.00298	0.00318	CcSEcCtD
Remifentanil—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00317	CcSEcCtD
Remifentanil—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00317	CcSEcCtD
Remifentanil—Rash—Colchicine—primary biliary cirrhosis	0.00295	0.00315	CcSEcCtD
Remifentanil—Dermatitis—Colchicine—primary biliary cirrhosis	0.00295	0.00315	CcSEcCtD
Remifentanil—Headache—Colchicine—primary biliary cirrhosis	0.00293	0.00313	CcSEcCtD
Remifentanil—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00307	CcSEcCtD
Remifentanil—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00307	CcSEcCtD
Remifentanil—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00297	CcSEcCtD
Remifentanil—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00297	CcSEcCtD
Remifentanil—Nausea—Colchicine—primary biliary cirrhosis	0.00278	0.00297	CcSEcCtD
Remifentanil—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00267	0.00285	CcSEcCtD
Remifentanil—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00267	0.00285	CcSEcCtD
Remifentanil—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00283	CcSEcCtD
Remifentanil—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00283	CcSEcCtD
Remifentanil—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00283	CcSEcCtD
Remifentanil—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00283	CcSEcCtD
Remifentanil—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00281	CcSEcCtD
Remifentanil—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00281	CcSEcCtD
Remifentanil—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00267	CcSEcCtD
Remifentanil—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00267	CcSEcCtD
Remifentanil—OPRD1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00243	0.0428	CbGpPWpGaD
Remifentanil—OPRK1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00214	0.0376	CbGpPWpGaD
Remifentanil—Pethidine—ALB—primary biliary cirrhosis	0.00192	0.311	CrCbGaD
Remifentanil—OPRM1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.0018	0.0318	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—CD3D—primary biliary cirrhosis	0.00171	0.0301	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—MAP3K14—primary biliary cirrhosis	0.00149	0.0262	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00134	0.0236	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—COL1A1—primary biliary cirrhosis	0.00121	0.0213	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00118	0.0207	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00115	0.0202	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00104	0.0183	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.001	0.0177	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000996	0.0175	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000966	0.017	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000912	0.016	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000897	0.0158	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000877	0.0154	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000849	0.0149	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000847	0.0149	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—CD40LG—primary biliary cirrhosis	0.000843	0.0148	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—RPS6KB1—primary biliary cirrhosis	0.00082	0.0144	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—IL4—primary biliary cirrhosis	0.00082	0.0144	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000786	0.0138	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000771	0.0136	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000769	0.0135	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000768	0.0135	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000716	0.0126	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000698	0.0123	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000674	0.0119	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000664	0.0117	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.00065	0.0114	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000612	0.0108	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000585	0.0103	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000569	0.01	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000542	0.00953	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000531	0.00935	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000517	0.0091	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000513	0.00903	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000475	0.00836	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000466	0.0082	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000466	0.0082	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000457	0.00804	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000433	0.00763	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000409	0.00719	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000401	0.00706	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000401	0.00705	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000394	0.00693	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000393	0.00692	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.00039	0.00686	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000363	0.00639	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000346	0.00608	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000345	0.00607	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000342	0.00602	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000339	0.00596	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000331	0.00582	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000329	0.00579	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000319	0.00561	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000313	0.0055	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000306	0.00539	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.0003	0.00528	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.0003	0.00528	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000291	0.00513	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00029	0.0051	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000289	0.00509	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000289	0.00508	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000277	0.00487	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000274	0.00483	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000273	0.0048	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000269	0.00474	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000263	0.00463	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000263	0.00463	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000262	0.0046	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000245	0.00431	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000244	0.00429	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000243	0.00427	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000239	0.00421	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000238	0.00419	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000232	0.00408	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000229	0.00404	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000222	0.00391	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000222	0.00391	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000209	0.00367	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000205	0.00361	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000202	0.00355	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000199	0.00351	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000194	0.00341	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000184	0.00324	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000177	0.00312	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000176	0.00311	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000175	0.00307	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000162	0.00284	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000161	0.00283	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000156	0.00275	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000155	0.00274	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000149	0.00262	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000148	0.0026	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000142	0.0025	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000141	0.00248	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000137	0.00241	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000137	0.0024	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000135	0.00237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000131	0.00231	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000131	0.0023	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000129	0.00228	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000124	0.00219	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000122	0.00215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000119	0.0021	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000118	0.00208	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000116	0.00204	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000114	0.002	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000113	0.00198	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00011	0.00194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000107	0.00189	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000105	0.00185	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000102	0.0018	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	9.97e-05	0.00176	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.87e-05	0.00174	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MMP3—primary biliary cirrhosis	9.6e-05	0.00169	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL5—primary biliary cirrhosis	9.06e-05	0.00159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGT—primary biliary cirrhosis	8.96e-05	0.00158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.39e-05	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—primary biliary cirrhosis	8.34e-05	0.00147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP3—primary biliary cirrhosis	7.65e-05	0.00135	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.65e-05	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—primary biliary cirrhosis	7.58e-05	0.00133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.35e-05	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—primary biliary cirrhosis	7.22e-05	0.00127	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7e-05	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—primary biliary cirrhosis	6.71e-05	0.00118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.7e-05	0.00118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.33e-05	0.00111	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.22e-05	0.00109	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.13e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.06e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—primary biliary cirrhosis	6.04e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—primary biliary cirrhosis	5.67e-05	0.000998	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.67e-05	0.000997	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—primary biliary cirrhosis	5.35e-05	0.000941	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—primary biliary cirrhosis	5.35e-05	0.000941	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.32e-05	0.000935	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—primary biliary cirrhosis	5.3e-05	0.000932	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.18e-05	0.000912	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—primary biliary cirrhosis	4.69e-05	0.000826	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TYK2—primary biliary cirrhosis	4.52e-05	0.000795	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.49e-05	0.00079	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—primary biliary cirrhosis	4.48e-05	0.000788	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—primary biliary cirrhosis	3.96e-05	0.000698	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.96e-05	0.000697	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.56e-05	0.000626	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.52e-05	0.000619	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.35e-05	0.000589	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.12e-05	0.000549	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.09e-05	0.000543	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.64e-05	0.000464	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.61e-05	0.000459	CbGpPWpGaD
